IRIS
GIORDANO, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.491
EU - Europa 5.959
AS - Asia 1.908
SA - Sud America 19
AF - Africa 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.484
DE - Germania 1.394
CN - Cina 1.283
IT - Italia 1.179
SE - Svezia 995
FR - Francia 827
UA - Ucraina 506
SG - Singapore 449
FI - Finlandia 385
GB - Regno Unito 331
RU - Federazione Russa 140
IE - Irlanda 69
IN - India 55
BE - Belgio 48
KR - Corea 42
VN - Vietnam 19
CZ - Repubblica Ceca 13
IR - Iran 13
NL - Olanda 12
BR - Brasile 9
ES - Italia 9
PT - Portogallo 8
AR - Argentina 7
RO - Romania 7
TH - Thailandia 7
IL - Israele 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
CA - Canada 4
HK - Hong Kong 4
JP - Giappone 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CH - Svizzera 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
HR - Croazia 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
RS - Serbia 2
UG - Uganda 2
BT - Bhutan 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
GL - Groenlandia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MC - Monaco 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
RE - Reunion 1
SA - Arabia Saudita 1
SI - Slovenia 1
SL - Sierra Leone 1
ZA - Sudafrica 1
Totale 22.391
Salva come PNG Salva come JPEG
Città #
Fairfield 1.754
Woodbridge 1.525
Chandler 1.490
Jacksonville 1.265
Houston 928
Ashburn 854
Cambridge 797
Nyköping 764
Seattle 687
Wilmington 594
Ann Arbor 565
Lawrence 393
Roxbury 390
Nanjing 362
Singapore 342
Bari 326
Des Moines 244
Beijing 226
Boardman 190
New York 190
Princeton 159
Inglewood 136
San Diego 102
Nanchang 88
Jiaxing 84
Shenyang 80
Hebei 79
Santa Clara 72
Brooklyn 71
Dublin 64
Dearborn 61
Helsinki 60
Paris 53
Brussels 47
Los Angeles 47
Milan 46
Tianjin 43
London 40
Changsha 39
Redwood City 39
Rome 35
Romola 34
Munich 33
Pune 28
Modugno 23
Guangzhou 22
Padova 22
Shanghai 21
Norwalk 20
Auburn Hills 17
Jinan 16
Dong Ket 15
Napoli 15
Washington 15
Torino 14
Hefei 13
Genoa 12
Prescot 12
Brno 11
Falls Church 11
Ningbo 11
Redmond 11
Hounslow 10
Turin 10
Zhengzhou 10
Ardabil 9
Edinburgh 9
Florence 9
San Severo 9
Wuhan 9
Leawood 8
Palermo 8
San Francisco 8
Simi Valley 8
Augusta 7
Jinhua 7
Naples 7
New Bedfont 7
San Giovanni Rotondo 7
Boydton 6
Cutrofiano 6
Genova 6
Grumo Appula 6
Kunming 6
Lisbon 6
Nürnberg 6
Strasbourg 6
São Luís 6
Taizhou 6
Treviso 6
Bologna 5
Catania 5
Chiswick 5
Fuzhou 5
Indiana 5
Kilburn 5
Mumbai 5
Ostuni 5
Phoenix 5
Salerno 5
Totale 15.965
Salva come PNG Salva come JPEG
Nome #
Correzione dell'ipofibrinogenemia acquisita con concentrato di fibrinogeno in bambini affetti da LLA in trattamento con Asparaginasi. L'esperienza di due centri AIEOP 326
Endothelial and Metabolic Function Interactions in Overweight/Obese Children. 202
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. 143
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study 136
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 134
Association of congenital afibrinogenemia and k-dependent protein C deficiency - a case report 122
Cognitive, emotional, and behavioral profile in children and adolescents with chronic pain associated with rheumatic diseases: A case-control study 120
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 117
Thromboembolic risk in children with nephrotic syndrome 116
Coagulation inhibitors (protein C and antithrombin III) in the preterm infant during the first month of life 114
DETERMINATION OF von WILLEBRAND FACTOR AND FACTOR XIII IN CHILDREN WITH SCHONLEIN HENOCH SYNDROME 113
Von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura 111
Porpora trombocitopenica idiopatica (immune) (PTI) acuta in età pediatrica.Linee guida AIEOP per la diagnosi ed il trattamento 109
Carotenoids and Cardiovascular Risk 108
Thrombin generation in children with acute lymphoblastic leukemia (ALL): effects of ALL immunophenotypic subgroup on inherited thrombotic risk factors 107
Vascular Function and Myocardial Performance Indices in Children Born Small for Gestational Age. 107
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 106
Serum D vitamin levels in children with immune thrombocytopenia 105
Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects 103
Authors' Reply to "CD10 in the Cytological Diagnosis of Endobronchial Endometriosis" 101
Risk factors for subclinical atherosclerosis in diabetic and obese children 101
Creazione del network italiano Asplenia per la gestione coordinata a livello nazionale dei pazienti asplenici: il ruolo dell'AIEOP e di altre società scientifiche 101
Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project 101
Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. 101
Issues in pediatric haemophilia care 100
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort 99
Coagulation and fibrinolytic systems in the ill preterm newborn 98
APC resistance in thalassemic patients:an under-lying cause of thrombosis 97
B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy 97
Can Anti-Thyroid Antibodies Influence the Outcome of Primary Chronic Immune Thrombocytopenia in Children? 97
Vaccine administration and the development of immune thrombocytopenic purpura in children 96
Thromboembolic risk in children with nephrotic syndrome 96
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 96
A Narrative Approach to Describe QoL in Children With Chronic ITP 96
Autoimmune haematological disorders in two Italian children with Kabuki Syndrome 95
New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey 95
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 95
APC Resistance in thalassemic patients and under-lying cause of thrombosis 92
Chronic immune thrombocytopenia in childhood 92
Catheter-related infections in pediatric patients with cancer. 91
Impact of sleep respiratory disorders on endothelial function in children. 91
Analysis of Circulating Mediators of Bone Remodeling in Prader-Willi Syndrome 91
Contemporary deficiency of vitamin K-dependents procoagulants and anticoagulants (PC) in late hemorrhagic disease of newborn 91
Cardiovascular dysfunction and vitamin D status in childhood acute lymphoblastic leukemia survivors 90
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 90
Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians 90
Thrombin activation in thalassemia major: effect of iron chelators and splenectomy 89
Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood. 89
Bleeding management in pediatric patients. 89
Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry 87
Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment 87
The role of endothelial dysfunction and oxidative stress in cerebrovascular diseases 87
Coagulation inhibitors (PC and ATIII) in preterm infants during the first month of life 86
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study 86
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 86
Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents 86
Clinical Data of Neonatal Systemic Thrombosis 86
ANKRD26-related thrombocytopenia and myeloid malignancies. 85
null 85
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 85
A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns. 85
Resistance to activated protein C in thalassaemic patients: an underlying cause of thrombosis 85
Endothelial dysfunction and cardiovascular risk factors in childhood acute lymphoblastic leukemia survivors Autori 85
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 84
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 83
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 83
K-dependent coagulant and anticoagulant factors deficiency in late haemorrhagic disease of the newborn 83
Present and Future of Pediatric Hemophilia Treatment 82
Analysis of coagulation and fibrinolysis parameters in obese children and adolescents 82
Thromboembolic risk in children with nephrotic syndrom. 81
ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's 81
APC resistance in thalassemic patients 81
Mechanisms of enhanced osteoclastogenesis in Alkaptonuria 81
HHT in childhood: screening for special patients 80
null 80
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia 80
null 80
Effects of deferiprone on immune status and cytokine pattern in thalassaemia major 79
Unbalanced coagulation-fibrinolysis potential during L-Asparaginase therapy in children with acute lymphoblastic leukaemia 79
Management of liver disease in thalassemia: main drug targets for a correct therapy 79
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial 79
Alagille syndrome: A novel mutation in JAG1 gene 79
Association of interleukin-(IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura. 78
Alterazioni coagulative e fibrinolitiche nel neonato pretermine affetto da: IRDS, asfissia alla nascita, sepsi 78
Monoclonal gammopathy of undetermined significance in pediatric kidney transplant: a possible role of Epstein-Barr virus. 78
Analysis of three genetic polymorphisms as risk factors for thrombosis 78
Protein C deficiency in two children with cerebral thrombosis 78
Splenectomy in children with chronic ITP: Long-term efficacy and relation between its outcome and responses to previous treatments 78
How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review. 78
La proteina Z e i PIVKA II in età neonatale 77
Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma 77
null 77
Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia 77
Successful treatment with Protein C of febrile neutropenia in pediatric patients during cancer therapy 76
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 76
Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis. 76
Langerhans cell histiocytosis in a pediatric patient with thrombocytopenia-absent radius syndrome and 1q21.1 deletion: case report and proposal of a rapid molecular diagnosis of 1q21.1 deletion. 76
Effect of oversulfated dermatan sulfate derivatives on platelet aggregation 76
Trombosi dell'arteria ulnare in bambino con sindrome nefrosica 75
Assetto immunitario e marcatori endoteliali nella vasculite di Schonlein-Henoch in età pediatrica 75
Totale 9.467
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.711 0 0 0 377 492 441 511 393 561 270 507 159
2020/20213.096 329 180 266 223 358 137 282 269 296 381 197 178
2021/20222.866 149 523 46 187 82 108 115 182 154 114 457 749
2022/20234.000 627 383 253 371 507 526 59 422 648 28 95 81
2023/20241.367 117 283 72 149 113 324 41 55 26 37 19 131
2024/20251.006 179 103 671 53 0 0 0 0 0 0 0 0
Totale 23.299